Form 8-K - Current report:
SEC Accession No. 0001683168-25-004948
Filing Date
2025-07-07
Accepted
2025-07-07 16:01:40
Documents
12
Period of Report
2025-07-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT phio_8k.htm   iXBRL 8-K 31322
  Complete submission text file 0001683168-25-004948.txt   197606

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phio-20250707.xsd EX-101.SCH 3020
3 XBRL LABEL FILE phio-20250707_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE phio-20250707_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3729
Mailing Address 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406
Business Address 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

EIN.: 453215903 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 251107945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)